Musgrove EA - Search Results

1

Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancer.

Kenny FS, Hui R, Musgrove EA, Gee JM, Blamey RW, Nicholson RI, Sutherland RL, Robertson JF. Kenny FS, et al. Among authors: musgrove ea. Clin Cancer Res. 1999 Aug;5(8):2069-76. Clin Cancer Res. 1999. PMID: 10473088

2

Inducible overexpression of cyclin D1 in breast cancer cells reverses the growth-inhibitory effects of antiestrogens.

Wilcken NR, Prall OW, Musgrove EA, Sutherland RL. Wilcken NR, et al. Among authors: musgrove ea. Clin Cancer Res. 1997 Jun;3(6):849-54. Clin Cancer Res. 1997. PMID: 9815758

3

Cyclin D1 and estrogen receptor messenger RNA levels are positively correlated in primary breast cancer.

Hui R, Cornish AL, McClelland RA, Robertson JF, Blamey RW, Musgrove EA, Nicholson RI, Sutherland RL. Hui R, et al. Among authors: musgrove ea. Clin Cancer Res. 1996 Jun;2(6):923-8. Clin Cancer Res. 1996. PMID: 9816251

4

INK4a gene expression and methylation in primary breast cancer: overexpression of p16INK4a messenger RNA is a marker of poor prognosis.

Hui R, Macmillan RD, Kenny FS, Musgrove EA, Blamey RW, Nicholson RI, Robertson JF, Sutherland RL. Hui R, et al. Among authors: musgrove ea. Clin Cancer Res. 2000 Jul;6(7):2777-87. Clin Cancer Res. 2000. PMID: 10914724

5

Differential effects of phorbol ester on epidermal growth factor receptors in estrogen receptor-positive and -negative breast cancer cell lines.

Koga M, Musgrove EA, Sutherland RL. Koga M, et al. Among authors: musgrove ea. Cancer Res. 1990 Aug 15;50(16):4849-55. Cancer Res. 1990. PMID: 2379149

6

Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells.

Watts CK, Sweeney KJ, Warlters A, Musgrove EA, Sutherland RL. Watts CK, et al. Among authors: musgrove ea. Breast Cancer Res Treat. 1994;31(1):95-105. doi: 10.1007/BF00689680. Breast Cancer Res Treat. 1994. PMID: 7981461

7

Inducible expression of cyclin D1 in T-47D human breast cancer cells is sufficient for Cdk2 activation and pRB hyperphosphorylation.

Musgrove EA, Sarcevic B, Sutherland RL. Musgrove EA, et al. J Cell Biochem. 1996 Mar 1;60(3):363-78. doi: 10.1002/(SICI)1097-4644(19960301)60:3%3C363::AID-JCB8%3E3.0.CO;2-U. J Cell Biochem. 1996. PMID: 8867812

8

EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survival.

Hui R, Ball JR, Macmillan RD, Kenny FS, Prall OW, Campbell DH, Cornish AL, McClelland RA, Daly RJ, Forbes JF, Blamey RW, Musgrove EA, Robertson JF, Nicholson RI, Sutherland RL. Hui R, et al. Among authors: musgrove ea. Oncogene. 1998 Aug 27;17(8):1053-9. doi: 10.1038/sj.onc.1202023. Oncogene. 1998. PMID: 9747885

9

Cyclin D1 overexpression induces progestin resistance in T-47D breast cancer cells despite p27(Kip1) association with cyclin E-Cdk2.

Musgrove EA, Hunter LJ, Lee CS, Swarbrick A, Hui R, Sutherland RL. Musgrove EA, et al. J Biol Chem. 2001 Dec 14;276(50):47675-83. doi: 10.1074/jbc.M106371200. Epub 2001 Oct 4. J Biol Chem. 2001. PMID: 11590147 Free article.

10

Steroids, growth factors, and cell cycle controls in breast cancer.

Musgrove EA, Sutherland RL. Musgrove EA, et al. Cancer Treat Res. 1991;53:305-31. doi: 10.1007/978-1-4615-3940-7_15. Cancer Treat Res. 1991. PMID: 1672085 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

205 results

Search Page

Filters